Q2 Holdings Aktie

Q2 Holdings für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN DE: A1XEYE / ISIN: US74736L1098

<
Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Historisch
>
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
14.08.2025 00:00:02

The Oncology Institute Q2 Revenue Surges

The Oncology Institute (NASDAQ:TOI) reported fiscal second quarter ended June 30, 2025, earnings on August 13, 2025, posting 21.5% year-over-year revenue growth to $119.8 million. Pharmacy revenue increased 41% year over year, and over 50,000 new capitated lives were added. Management reiterated full-year revenue guidance of $460 million to $480 million for fiscal year 2025, expects positive adjusted EBITDA (non-GAAP) in the fourth quarter, and highlighted meaningful scale expansion within Florida, Nevada, and California. Key insights below detail pharmacy margin expansion, the strategic shift to fully delegated risk models beyond California, and operating leverage gains from technology integration.Pharmacy revenue accounted for 52% of total revenue in the fiscal second quarter ended June 30, 2025, with year-over-year growth of 41% in pharmacy revenue, and the company anticipates another pharmacy location will open in Florida in the second half of the year. Technological investments and increased patient volumes have contributed to improved procurement efficiency and drug margin expansion, as discussed on the earnings call, focusing on oral specialty (Part D) drugs where margin improvements are most actionable.Improved pharmacy scale materially enhances purchasing leverage, driving durable gross margin growth while steadily reducing prescription leakage and positioning the company to offset industry-wide drug cost inflation.Continue readingWeiter zum vollständigen Artikel bei MotleyFool

Analysen zu The Oncology Institute Inc Registered Shsmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

Q2 Holdings Inc 57,00 0,88% Q2 Holdings Inc
The Oncology Institute Inc Registered Shs 3,64 5,81% The Oncology Institute Inc Registered Shs